John Harlow

John Harlow is a seasoned pharmaceutical executive with extensive experience in commercial leadership roles. Currently serving as Chief Commercial Officer at Melinta Therapeutics since March 2021, John also contributes as a member of the Board of Advisors at BranchLab. Prior positions include Chief Commercial Officer at Baudax Bio and Executive Vice President of Commercial at Recro Pharma, Inc., where John managed both sales and marketing strategies. Notably, John held key leadership roles at Endo Pharmaceuticals, Shionogi Inc., and King Pharmaceuticals, where achievements included successful product launches and operational enhancements. John holds a Bachelor's Degree in Biology from Lehigh University and an MBA in Pharmaceutical Management from Seton Hall University.